FDA in the Trump Administration: What Can We Expect? Catalyst to Speak at 9th Annual Biotech Showcase Workshop

What can we anticipate from FDA in the Trump Administration? How might new policies impact innovation and product development? Join us on Jan. 10 as Catalyst President Nancy Bradish Myers offers insights on these topics, along with fellow panelists David Fox, Partner, Hogan Lovells, Sara Radcliffe, President & CEO, California Life Sciences Association, and moderator Joseph Gulfo, Executive Director, Lewis Center for Healthcare Innovation and Technology, Fairleigh Dickinson University.